Zydus Lifesciences Limited

NSE:ZYDUSLIFE.NS

970.35 (INR) • At close November 8, 2024
Bedrijfsnaam Zydus Lifesciences Limited
Symbool ZYDUSLIFE.NS
Munteenheid INR
Prijs 970.35
Beurswaarde 976,395,280,500
Dividendpercentage 0.6%
52-weken bereik 606.05 - 1,324.3
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Sharvil Pankajbhai Patel
Website https://www.zyduslife.com

An error occurred while fetching data.

Over Zydus Lifesciences Limited

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty

Vergelijkbare Aandelen

Abbott India Limited logo

Abbott India Limited

ABBOTINDIA.NS

28,553.1 INR

Alkem Laboratories Limited logo

Alkem Laboratories Limited

ALKEM.NS

5,706.5 INR

Biocon Limited logo

Biocon Limited

BIOCON.NS

321.3 INR

Max Healthcare Institute Limited logo

Max Healthcare Institute Limited

MAXHEALTH.NS

1,079.25 INR

Aurobindo Pharma Limited logo

Aurobindo Pharma Limited

AUROPHARMA.NS

1,327.55 INR

Laurus Labs Limited logo

Laurus Labs Limited

LAURUSLABS.NS

499.35 INR

Torrent Pharmaceuticals Limited logo

Torrent Pharmaceuticals Limited

TORNTPHARM.NS

3,199.85 INR

Piramal Enterprises Limited logo

Piramal Enterprises Limited

PEL.NS

1,047.65 INR

Gland Pharma Limited logo

Gland Pharma Limited

GLAND.NS

1,777.6 INR

Lupin Limited logo

Lupin Limited

LUPIN.NS

2,104.6 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)